11:25am ET
Health and Healthcare
Can This FDA Approval Keep Lifting Geron?
Geron is one of the few biopharma winners on Tuesday, with the health care sector in general pushing slightly lower on the day.
Chris Lange
Companies
/Healthcare
Geron Corp
$1.53
â–² $0.00 (+0.00%) today
Markets closed · 12:20am ET
GERN Coverage
Page 2 Chris Lange 10:20am ET
Investing
4 Companies That Destroyed Shareholders Last Week
24/7 Wall Street has picked out a few companies posting the largest losses for the week, including Novavax and VimpelCom.
4:04pm ET
Investing
Kroger, Whole Foods in Monday’s 52-Week Low Club
September 12, 2016: Here are four stocks trading with relatively heavy volume among 56 equities making new 52-week lows in Monday’s session. NYSE advancers led decliners by more than 2 to 1…
12:45pm ET
Health and Healthcare
Is Geron Being Overly Punished?
Investors never like to see a stock they own drop 17%, but there is at least one view that maybe the drop is an opportunity for those with longer-term views who remain…
Jon C. Ogg 8:05am ET
Health and Healthcare
10 Speculative Biotech and Biohealth Stocks With Massive Analyst Upside Calls
Biotech is the one arena that still offers massive upside for investors — if they can pick the right companies that is. They could one day cure cancer, heart issues, diabetes and…
10:35am ET
Health and Healthcare
Can Geron Shares Still Ultimately Double?
A research report from Janney's Roy Buchanan issued on Friday included a fair value estimate for Geron shares that was more than 100% above the share price of the time.
Jon C. Ogg 8:50am ET
Investing
Top Analyst Upgrades and Downgrades: Best Buy, 3D Systems, EA, Gilead, Nokia, Shire, United Rentals and Many More
Friday's top analyst calls include Best Buy, 3D Systems, Electronic Arts, Gilead Sciences, Nokia, Shire and United Rentals.
10:40am ET
Health and Healthcare
4 Ignored Biotech Stocks for 2016
Biotech gets a lot of sustained attention, but some stocks still fall through the cracks, either due to recent failures or general lack of interest.
Trey Thoelcke 8:25am ET
Health and Healthcare
Huge PowerShares ETF Rebalance Means Massive Buying for 4 Biotech Stocks
On the close Tuesday, the PowerShares Dynamic exchange traded funds (ETFs) are set for a rebalance. These four stocks that are expected to have huge buying on the close Tuesday.
11:35am ET
Health and Healthcare
What Licensing Imetelstat Will Mean for Geron
Geron hasannounced that it entered into an exclusive worldwide license and collaboration agreement with Janssen Biotech to develop and commercialize imetelstat.
12:25pm ET
Health and Healthcare
Is Geron Back From the Dead?
The FDA gave Geron some good news Monday morning when it removed the clinical hold on the its investigational new drug application for imetelstat.
Chris Lange 11:09am ET
Investing
Nasdaq Falls Below 4,000 on Biotech, Technology Weakness
bfishshadow via Wikimedia CommonsSince the beginning of the year, the Nasdaq Composite Index has given up more than 4% of its value, dropping from a high of around 4,357 in early March…
4:01pm ET
Investing
The 5 Stocks That Dominated the Market on Tuesday
thinkstockMarch 18, 2014: Markets opened higher on Tuesday and the number buyers rose throughout the day. There was something of a Vladimir Putin rally today following Russia’s formal annexation of Crimea, Putin’s…
4:01pm ET
Investing
The 4 Stocks That Dominated the Market on Wednesday
thinkstockMarch 12, 2014: Markets opened lower on Wednesday following a so-so trading day in Europe. Crude oil pulled back 2% after the EIA’s inventory report indicated a larger inventory gain than expected.…
9:45am ET
Health and Healthcare
Back to Normalcy at Geron
Geron is getting a reality check on Wednesday. After a recovery from years of disappointment, this is starting to feel again like the Geron that everyone knew before.
Jon C. Ogg